Our Doctors
Welcome to the Advanced Cellular Regeneration Center! We are dedicated to pioneering breakthroughs in regenerative medicine, focusing on harnessing the power of cellular biology to rejuvenate and restore health. Our mission is to provide innovative treatments that empower individuals to reclaim their vitality and improve their quality of life.
Jeffrey N Weiss, MD
Dr. Jeffrey N. Weiss is President of The American College of Regenerative Medicine and performed the first retinal stem cell surgery in the world in 2010. He is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II, the largest retinal and optic nerve stem cell studies in the world; The Neurologic Stem Cell Treatment Study; The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study; and The Alzheimer’s, Cognitive Impairment and Autism Treatment Study. The studies are Institutional Review Board (IRB) approved, registered with NIH and listed on ClinicalTrials.gov.
Jeffrey N. Weiss, M.D., is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at the Massachusetts Institute of Technology. He entered college at 16 years of age, and medical school at age 19 on full scholarships. While in medical school he obtained a degree in Electrical Engineering, Magna Cum Laude with distinction, and graduated from Medical School, Summa Cum Laude, at 23 years of age.
Dr. Weiss is the author of more than 100 publications, including 25 books, holds more than 20 U.S. and foreign patents and has been a Reviewer for multiple scholarly journals. He has served as a Visiting Professor, performed surgery, and lectured both nationally and internationally. Dr. Weiss is also the founder of two companies, Ocular Research Associates Inc., and Micron Ophthalmic, Inc., which have manufactured and sold Dr. Weiss’ inventions worldwide.
Dr. Weiss was the first to invent the equipment and develop the technique to safely perform retinal vessel cannulation. This surgery remains the only option for patients with severe stroke in the eye. He was also the first to report the use of hyperbaric oxygen treatment to successfully treat dry age-related macular degeneration and longer standing central retinal artery occlusions.
Biological and Cellular Research Papers
- https://www.youtube.com/watch?v=eKUBpQrkLy8
- https://agemed.org/cme-conferences/florida-april-2019/faculty/jeffrey-n-weiss-m-d/
- https://saudigerman.com/doctors/dr-jeffrey-n-weiss/
- https://tacrm.org/team/
- https://www.asrs.org/find-a-specialist/profile/1236/Jeffrey-N-Weiss
- https://www.emedevents.com/speaker-profile/jeffrey-n-weiss
Steven Levy, MD Clinical Study Director
He serves as Chair and Study Director for ongoing clinical studies including the Stem Cell Ophthalmology Treatment Study II (SCOTS2) and the Neurologic Stem Cell Treatment study (NEST). All use bone marrow derived stem cells, are Institutional Review Board approved, FDA compliant and registered with the United States National Institutes of Health on ClinicalTrials.gov .
Dr. Levy’s interest in leading edge medical technology and advancing medical care is long standing. He developed the first robotic approach to refractive eye surgery in mid 1980s and was actively involved in exploring areas of translational research including nanotechnology for ophthalmic applications. He was the first surgeon to perform topical anesthetic cataract surgery in New York City and among the first to use small incision and foldable lenses. His contributions to medical education include the training of many residents and setting the standard for minimally invasive eye surgery at three ophthalmology residency programs.
Following a career in the practice of ophthalmology, Dr. Levy transitioned into life science and healthcare business development, focusing on early stage companies. He is President of the Acoma Group which provides business development services for biopharmaceutical, medical and healthcare companies globally including an emerging stem cell start-up. He has taught Anatomy & Physiology at the college level, been an Advisory Board member consultant with Gerson-Lehrman, and CEO of an early stage neurotech company involving memory research and recovery . He routinely reviews manuscript submissions for a number of medical and scientific publications and has authored multiple journal publications.
Biological and Cellular Research Papers
- https://www.researchgate.net/profile/Steven-Levy-2
- https://sciprofiles.com/profile/306246
- https://pubmed.ncbi.nlm.nih.gov/26199618/
- https://sci.amegroups.org/article/view/19760/html
- https://www.amazon.com/Ophthalmology-Steven-Levy-Medical-Specialties/s?rh=n%3A157273011%2Cp_27%3ASteven%2BLevy
- https://sci.amegroups.org/article/view/32664/html
Services We Provide In Ophthalmology
- Age-Related Macular Degeneration – AMD
- Glaucoma
- Leber Hereditary Optic Neuropathy – LHON
- Low Vision*
- Macular Degeneration*
- Maculopathy
- Night Vision Loss*
- Nonarteritic Ischemic
- Optic Neuropathy – NAION
- Optic Atrophy
- Optic Nerve Disease
- Partial Blindness*
- Partial Vision Loss*
- Retina Atrophy
- Retinal Disease
- Retinitis Pigmentosa
- Retinopathy
- Stargardt Disease
Services We Provide For Neurological Disorders
- ALS
- Alzheimer Disease
- Amyotrophic Lateral Sclerosis
- Cadasil
- Cerebral Hemorrhage
- Cerebral Infarction
- Cerebral Ischemia
- Cerebral Stroke
- Chronic Traumatic Encephalopathy
- Cognitive Impairment
- Dementia
- Diabetic Neuropathies
- Frontotemporal Dementia – FTD
- Lewy Body Disease
- Lewy Body Variant of
- MSA – Multiple System Atrophy
- Multi-System Degeneration
- Neurodegenerative Diseases
- Neuropathy
- Parkinson
- Progressive Supranuclear Palsy
- Stroke
- Traumatic Brain Injury
